What is Tofacitinib?

Category: Prescription Drugs

Most popular types: Xeljanz Xeljanz XR

false

Tofacitinib is an oral medication that is known as a disease modifying antirheumatic drug. It is used in the treatment of adult patients with moderately- to severely-active rheumatoid arthritis who are unable to take or who have had an inadequate response to methotrexate.

Reported purpose & perceived effectiveness
Purpose Patients Evaluations Perceived Effectiveness
Rheumatoid arthritis 52 21
Pain 2 1
Psoriatic arthritis 2 1
Stiffness in morning 2 0
Ulcerative colitis 2 0
Alopecia areata 1 1

Show all 10 reasons taken


  • Major
  • Moderate
  • Slight
  • None
  • Can't tell

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations Percentage
Severe 5
Moderate 3
Mild 5
None 14

Commonly reported side effects and conditions associated with Tofacitinib

Side effect Patients Percentage
Headaches 5
High cholesterol (hypercholesterolemia) 2
Stomach pain 2
Biliary reflux 1
Dizziness 1
Fatigue 1

Show all 14 reported side effects

Dosages

Based on patients currently taking Tofacitinib

Dosage Patients Percentage
11 mg daily 7
5 mg twice daily 6
5 mg daily 2
10 mg twice daily 2

Why patients stopped taking Tofacitinib

Multiple reasons could be selected

Reason Patients Percentage
Did not seem to work 10
Doctor's advice 4
Side effects too severe 4
Change in health plan coverage 2
Other 2
Expense 1
See all 17 patients who've stopped taking Tofacitinib

Duration

Currently taking Tofacitinib

Duration Patients Percentage
6 months - 1 year 1
1 - 2 years 7
2 - 5 years 7
5 - 10 years 1

Stopped taking Tofacitinib

Duration Patients Percentage
Less than 1 month 7
1 - 6 months 6
6 months - 1 year 1
1 - 2 years 2
2 - 5 years 1
Adherence
Adherence Evaluations Percentage
Always 23
Usually 3
Sometimes 0
Never taken as prescribed 1
Burden
Burden Evaluations Percentage
Very hard to take 0
Somewhat hard to take 0
A little hard to take 1
Not at all hard to take 26
Cost per month
Cost per month Evaluations Percentage
$200+ 2
$100-199 2
$50-99 2
$25-49 1
< $25 16
Not specified 4

What people switch to and from

Patients started taking Tofacitinib after stopping:

Treatment Patients Percentage
Adalimumab (Humira) 10
Methotrexate (Trexall) 10
Etanercept (Enbrel SureClick) 6
Tocilizumab (Actemra) 5
Abatacept (Orencia) 4

Show all 16 treatments patients report switching from

Patients stopped taking Tofacitinib and switched to:

Treatment Patients Percentage
Abatacept (Orencia) 3
Adalimumab (Humira) 3
Etanercept (Enbrel SureClick) 2
Infliximab (Remicade) 1
Minocycline (Minocin) 1

Show all 9 treatments patients report switching to

Last updated:
There are no evaluations for Tofacitinib.